Fortrea Holdings FTRE
NASDAQ FTRE
$18.26 -0.36 (-1.93%)
As of: Sep 4, 2026 · 11:45 AM EDT

Fortrea Holdings (FTRE) EBIT (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly EBIT came in at $14.8 million in Q2 2026, up 104.48% YoY from $7.2 million in Q2 2025, and up 535.29% on a QoQ basis from -$3.4 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) EBIT (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of EBIT data on file, last reported at $14.8 million in Q2 2026.

  • Quarterly EBIT rose 104.48% year-over-year to $14.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$10.8 million (up 98.83% YoY) and the FY2025 annual result came in at -$872.6 million, down 438.97% from the prior year.
  • EBIT grew to $14.8 million in Q2 2026, from -$3.4 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $71.2 million in Q2 2022 to a low of -$520.1 million in Q1 2025.
  • A 5-year average of -$49.2 million and a median of -$8.6 million in 2025 frame the typical range for EBIT.
  • Annual changes were most pronounced in 2025 — EBIT plunged 1290.64% — and 2026, when it soared 104.48%.
  • Tracing FTRE's EBIT over 5 years: stood at $14.3 million in 2022, then plunged by 267.83% to -$24.0 million in 2023, then sank by 131.67% to -$55.6 million in 2024, then soared by 75.54% to -$13.6 million in 2025, then surged by 208.82% to $14.8 million in 2026.
  • The last three EBIT figures came in at $14.8 million (Q2 2026), -$3.4 million (Q1 2026), and -$13.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn 493.00 Mn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -505.13 Mn
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn - 133.12 Mn
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn -1.55 Mn
10 Fortrea Holdings 1.73 Bn 1.56 Bn 139.20 Mn 14.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.80 Mn
Mar 31, 2026 -3.40 Mn
Dec 31, 2025 -13.60 Mn
Sep 30, 2025 -8.60 Mn
Jun 30, 2025 -330.30 Mn
Mar 31, 2025 -520.10 Mn
Dec 31, 2024 -55.60 Mn
Sep 30, 2024 -18.00 Mn
Jun 30, 2024 -50.90 Mn
Mar 31, 2024 -37.40 Mn
Dec 31, 2023 -24.00 Mn
Sep 30, 2023 10.30 Mn
Jun 30, 2023 31.60 Mn
Mar 31, 2023 14.10 Mn
Dec 31, 2022 14.30 Mn
Sep 30, 2022 68.90 Mn
Jun 30, 2022 71.20 Mn